Matches in Wikidata for { <http://www.wikidata.org/entity/Q65382212> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q65382212 description "clinical trial" @default.
- Q65382212 description "ensayu clínicu" @default.
- Q65382212 description "klinisch onderzoek" @default.
- Q65382212 description "клінічне випробування" @default.
- Q65382212 name "Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer" @default.
- Q65382212 name "Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer" @default.
- Q65382212 type Item @default.
- Q65382212 label "Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer" @default.
- Q65382212 label "Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer" @default.
- Q65382212 prefLabel "Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer" @default.
- Q65382212 prefLabel "Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer" @default.
- Q65382212 P1132 Q65382212-7D379B09-145B-4F8E-AB89-8A28D15967F7 @default.
- Q65382212 P1476 Q65382212-BE695781-A825-4249-9D84-679DDE119A05 @default.
- Q65382212 P17 Q65382212-A99DD78C-A96A-4B01-A170-D31619028A4C @default.
- Q65382212 P1813 Q65382212-B485E902-F10F-48D6-A377-E741E8C3BCC0 @default.
- Q65382212 P2899 Q65382212-D8CF0793-EA91-4395-B23C-E6FAA242C75A @default.
- Q65382212 P3098 Q65382212-5BE047F3-AA97-490C-83CE-F85497C00A8A @default.
- Q65382212 P31 Q65382212-D8047C17-9208-4BCF-A7FE-491ED31CA6B3 @default.
- Q65382212 P4844 Q65382212-01952C54-13C7-4B49-B79C-6B7243436C78 @default.
- Q65382212 P4844 Q65382212-6B749F68-DA99-423C-9B6F-6F5F3669A9FE @default.
- Q65382212 P4844 Q65382212-AEAE7CAD-9B40-4100-8E07-CEC35A91DB52 @default.
- Q65382212 P580 Q65382212-FDC16BFF-CE16-422D-B4C7-15C6F45315A3 @default.
- Q65382212 P582 Q65382212-72A39E58-F523-4AF5-8D0C-D529B6F76F42 @default.
- Q65382212 P6099 Q65382212-2AFF2E56-C513-442F-847D-ED94FEEBE4DF @default.
- Q65382212 P6153 Q65382212-642E134A-1EE3-4C9A-8665-5574F7259431 @default.
- Q65382212 P8363 Q65382212-FCB3A9D2-947E-4EDF-A9F4-A286C25009E0 @default.
- Q65382212 P1132 "+41" @default.
- Q65382212 P1476 "A Phase II Study of Abraxane®, Carboplatin and Bevacizumab in "Triple Negative" (Demonstrating No Expression for Estrogen, Progesterone, or Her2 Receptors) Metastatic Breast Cancer" @default.
- Q65382212 P17 Q30 @default.
- Q65382212 P1813 "ABC" @default.
- Q65382212 P2899 "+18" @default.
- Q65382212 P3098 "NCT00479674" @default.
- Q65382212 P31 Q30612 @default.
- Q65382212 P4844 Q413299 @default.
- Q65382212 P4844 Q415588 @default.
- Q65382212 P4844 Q423762 @default.
- Q65382212 P580 "2007-05-01T00:00:00Z" @default.
- Q65382212 P582 "2014-03-01T00:00:00Z" @default.
- Q65382212 P6099 Q42824440 @default.
- Q65382212 P6153 Q30279912 @default.
- Q65382212 P8363 Q78089383 @default.